Association between Equol Production Status and Nonalcoholic Steatohepatitis

Equol is a metabolite of daidzein, a major soybean isoflavone with estrogenic and antioxidant activities. As the production of equol depends on the presence of certain members of the intestinal microflora, not all individuals can produce equol. We examined the relationship between NASH histological...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Takemi Akahane, Daisuke Kaya, Ryuichi Noguchi, Kosuke Kaji, Haruna Miyakawa, Yukihisa Fujinaga, Yuki Tsuji, Hiroaki Takaya, Yasuhiko Sawada, Masanori Furukawa, Koh Kitagawa, Takahiro Ozutsumi, Hideto Kawaratani, Kei Moriya, Tadashi Namisaki, Hitoshi Yoshiji
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/e33b1dba27d64357b7250887b7a5adcb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e33b1dba27d64357b7250887b7a5adcb
record_format dspace
spelling oai:doaj.org-article:e33b1dba27d64357b7250887b7a5adcb2021-11-11T17:19:07ZAssociation between Equol Production Status and Nonalcoholic Steatohepatitis10.3390/ijms2221119041422-00671661-6596https://doaj.org/article/e33b1dba27d64357b7250887b7a5adcb2021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11904https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Equol is a metabolite of daidzein, a major soybean isoflavone with estrogenic and antioxidant activities. As the production of equol depends on the presence of certain members of the intestinal microflora, not all individuals can produce equol. We examined the relationship between NASH histological features and equol production. In an animal model, obese OLETF rats were intraperitoneally injected with a porcine serum to augment liver fibrogenesis. Equol-rich soy product, SE5-OH was orally administered during the experimental period. Treatment with SE5-OH markedly attenuated the development of liver fibrosis and expression of alpha-smooth muscle actin. In clinical research, 38 NAFLD patients (13 men and 25 women) were included. The degree of fibrosis and ballooning in equol-nonproducers was significantly higher than in equol-producers in women. The percentage of nonproducers with NAFLD activity score (NAS) ≥ 5 was significantly higher than that of producers. None of the histological features were significantly different between nonproducers and producers in men. Decision tree analysis identified predictors for NAS ≥ 5 in women. The status of equol production was the strongest predictor, followed by fasting glucose. Since equol can be noninvasively detected in urine, it can be applied as a screening tool for the progression of NASH in women.Takemi AkahaneDaisuke KayaRyuichi NoguchiKosuke KajiHaruna MiyakawaYukihisa FujinagaYuki TsujiHiroaki TakayaYasuhiko SawadaMasanori FurukawaKoh KitagawaTakahiro OzutsumiHideto KawarataniKei MoriyaTadashi NamisakiHitoshi YoshijiMDPI AGarticleequolnonalcoholic steatohepatitisestrogenmenopauseBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11904, p 11904 (2021)
institution DOAJ
collection DOAJ
language EN
topic equol
nonalcoholic steatohepatitis
estrogen
menopause
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle equol
nonalcoholic steatohepatitis
estrogen
menopause
Biology (General)
QH301-705.5
Chemistry
QD1-999
Takemi Akahane
Daisuke Kaya
Ryuichi Noguchi
Kosuke Kaji
Haruna Miyakawa
Yukihisa Fujinaga
Yuki Tsuji
Hiroaki Takaya
Yasuhiko Sawada
Masanori Furukawa
Koh Kitagawa
Takahiro Ozutsumi
Hideto Kawaratani
Kei Moriya
Tadashi Namisaki
Hitoshi Yoshiji
Association between Equol Production Status and Nonalcoholic Steatohepatitis
description Equol is a metabolite of daidzein, a major soybean isoflavone with estrogenic and antioxidant activities. As the production of equol depends on the presence of certain members of the intestinal microflora, not all individuals can produce equol. We examined the relationship between NASH histological features and equol production. In an animal model, obese OLETF rats were intraperitoneally injected with a porcine serum to augment liver fibrogenesis. Equol-rich soy product, SE5-OH was orally administered during the experimental period. Treatment with SE5-OH markedly attenuated the development of liver fibrosis and expression of alpha-smooth muscle actin. In clinical research, 38 NAFLD patients (13 men and 25 women) were included. The degree of fibrosis and ballooning in equol-nonproducers was significantly higher than in equol-producers in women. The percentage of nonproducers with NAFLD activity score (NAS) ≥ 5 was significantly higher than that of producers. None of the histological features were significantly different between nonproducers and producers in men. Decision tree analysis identified predictors for NAS ≥ 5 in women. The status of equol production was the strongest predictor, followed by fasting glucose. Since equol can be noninvasively detected in urine, it can be applied as a screening tool for the progression of NASH in women.
format article
author Takemi Akahane
Daisuke Kaya
Ryuichi Noguchi
Kosuke Kaji
Haruna Miyakawa
Yukihisa Fujinaga
Yuki Tsuji
Hiroaki Takaya
Yasuhiko Sawada
Masanori Furukawa
Koh Kitagawa
Takahiro Ozutsumi
Hideto Kawaratani
Kei Moriya
Tadashi Namisaki
Hitoshi Yoshiji
author_facet Takemi Akahane
Daisuke Kaya
Ryuichi Noguchi
Kosuke Kaji
Haruna Miyakawa
Yukihisa Fujinaga
Yuki Tsuji
Hiroaki Takaya
Yasuhiko Sawada
Masanori Furukawa
Koh Kitagawa
Takahiro Ozutsumi
Hideto Kawaratani
Kei Moriya
Tadashi Namisaki
Hitoshi Yoshiji
author_sort Takemi Akahane
title Association between Equol Production Status and Nonalcoholic Steatohepatitis
title_short Association between Equol Production Status and Nonalcoholic Steatohepatitis
title_full Association between Equol Production Status and Nonalcoholic Steatohepatitis
title_fullStr Association between Equol Production Status and Nonalcoholic Steatohepatitis
title_full_unstemmed Association between Equol Production Status and Nonalcoholic Steatohepatitis
title_sort association between equol production status and nonalcoholic steatohepatitis
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/e33b1dba27d64357b7250887b7a5adcb
work_keys_str_mv AT takemiakahane associationbetweenequolproductionstatusandnonalcoholicsteatohepatitis
AT daisukekaya associationbetweenequolproductionstatusandnonalcoholicsteatohepatitis
AT ryuichinoguchi associationbetweenequolproductionstatusandnonalcoholicsteatohepatitis
AT kosukekaji associationbetweenequolproductionstatusandnonalcoholicsteatohepatitis
AT harunamiyakawa associationbetweenequolproductionstatusandnonalcoholicsteatohepatitis
AT yukihisafujinaga associationbetweenequolproductionstatusandnonalcoholicsteatohepatitis
AT yukitsuji associationbetweenequolproductionstatusandnonalcoholicsteatohepatitis
AT hiroakitakaya associationbetweenequolproductionstatusandnonalcoholicsteatohepatitis
AT yasuhikosawada associationbetweenequolproductionstatusandnonalcoholicsteatohepatitis
AT masanorifurukawa associationbetweenequolproductionstatusandnonalcoholicsteatohepatitis
AT kohkitagawa associationbetweenequolproductionstatusandnonalcoholicsteatohepatitis
AT takahiroozutsumi associationbetweenequolproductionstatusandnonalcoholicsteatohepatitis
AT hidetokawaratani associationbetweenequolproductionstatusandnonalcoholicsteatohepatitis
AT keimoriya associationbetweenequolproductionstatusandnonalcoholicsteatohepatitis
AT tadashinamisaki associationbetweenequolproductionstatusandnonalcoholicsteatohepatitis
AT hitoshiyoshiji associationbetweenequolproductionstatusandnonalcoholicsteatohepatitis
_version_ 1718432150064201728